Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]
A Phase 3 trial comparing linaprazan glurate to lansoprazole in participants with erosive esophagitis due to GERD is currently active but no…
-
CLINICAL_TRIALS trial_result · 2026-07-27Clinical Trial Update: Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. [Phase 3]
Phase 3 trial update evaluating maintenance of healing with oral NEXIUM (esomeprazole) in children aged 1 to 11 with erosive esophagitis; st…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. [Phase 3]
A Phase 3 trial in children aged 1 to 11 with erosive esophagitis shows endoscopic evidence that maintenance therapy with oral esomeprazole …
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets [Phase 1]
Phase 1 bioequivalence study comparing vonoprazan 20 mg film-coated tablets with Voquezna 20 mg vonoprazan tablets has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 study assessing the long-term safety of BLI5100 in patients with gastroesophageal reflux disease (including non-erosive reflux dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 study testing the efficacy and safety of BLI5100 in patients with erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily [Phase 1]
Phase 1 study evaluating vonoprazan concentrations in breast milk of healthy lactating women given 20 mg once daily or 20 mg twice daily; re…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 trial comparing JP-1366 20 mg with esomeprazole 40 mg in patients with erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety [Phase 4]
Phase 4 trial update evaluating long-term safety of vonoprazan in patients with erosive esophagitis; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole [Phase 2]
Phase 2 trial comparing X842 to lansoprazole for safety, tolerability, and healing of erosive esophagitis over 4 weeks, with a subsequent 4 …
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis [Phase 3]
Phase 3 trial comparing vonoprazan to lansoprazole in erosive esophagitis completed.
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease (GERD) has complet…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD) [Phase 3]
Phase 3 trial assessing YYD601 for erosive esophagitis has completed; results not detailed in provided snippet.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients [Phase 3]
A Phase III randomized, double-blind trial comparing Lafutidine, Famotidine, and Omeprazole in Korean patients with erosive esophagitis. The…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) [Phase 3]
Phase 3 trial evaluating DWP14012 for erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 study evaluating DWP14012 for maintaining healing in subjects with healed erosive esophagitis is ongoing; no results or status discl…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis [Phase 3]
Phase 3 trial comparing LXI-15028 with esomeprazole for erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis [Phase 3]
Phase 3 trial comparing vonoprazan to lansoprazole for maintenance therapy in erosive esophagitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis [Phase 3]
Phase 3 trial update on oral once-daily vonoprazan (TAK-438) for erosive esophagitis reports efficacy and safety data; results posted after …
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis [Phase 3]
Phase 3 trial update on the efficacy and safety of Dexlansoprazole for healing and maintaining healing of erosive esophagitis. The study was…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy [Phase 4]
Phase 4 trial updating rates of symptom relief and relapse prevention during esomeprazole therapy for erosive esophagitis.
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 study evaluating CJ-12420 for safety and efficacy in erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [Phase 2]
Zeria Pharmaceutical completed a Phase 2 clinical trial evaluating the efficacy and safety of Z-215 in erosive esophagitis. The study enroll…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
A completed clinical trial from the University of Pennsylvania investigates how bone structure and bone mass change with long-term proton pu…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
A Mayo Clinic-sponsored study on proton pump inhibitor-responsive eosinophilic esophagitis has completed, investigating whether PPI response…